Answers are grounded in this paper and cite their sources.
Introduction Anti-Mullerian hormone (AMH) is becoming commonly used in a range of clinical situations in reproductive medicine clinics. Much of the work on AMH is concentrated on its role as an ovarian reserve marker. The emerging value of AMH in the diagnosis and follow-up of patients with granulosa cell tumor (GCT) of the ovary and its vital role in predicting fertility preservation strategies in female patients needing chemotherapy for malignancies has expanded the use of AMH in clinical practice.
No takes yet. Share an insight, caveat, or question.
Umranikar et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: